Mehul Sheth

Thank you for the opportunity. Sir, first question is around, on your pipeline in liquid molecules. As of now, you have something like 100 plus kinds of active projects plus 10 molecules are in late phase. Can you give some highlight that how many of these projects are into a space of, we can say GLP or ADC kind of a segments? Any near -term visibility in terms of commercialization?

Okay. Thank you. Lastly, you already mentioned that there has been some timing-related shift in terms of customer ordering and that will be placed in the later part of the year. Given Q1 is down almost like a 25% on a Y oY basis. So, how do you see the full year as a growth number for the CRDMO as a business segment?

Keep looking at our business more on a YoY front.